NZ614208B2 - Auto-injector - Google Patents
Auto-injector Download PDFInfo
- Publication number
- NZ614208B2 NZ614208B2 NZ614208A NZ61420812A NZ614208B2 NZ 614208 B2 NZ614208 B2 NZ 614208B2 NZ 614208 A NZ614208 A NZ 614208A NZ 61420812 A NZ61420812 A NZ 61420812A NZ 614208 B2 NZ614208 B2 NZ 614208B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- carrier
- case
- chassis
- trigger button
- proximal
- Prior art date
Links
- 229940090047 Auto-Injector Drugs 0.000 title claims abstract description 90
- 239000007924 injection Substances 0.000 claims abstract description 105
- 238000002347 injection Methods 0.000 claims abstract description 104
- 239000003814 drug Substances 0.000 claims abstract description 28
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 239000000969 carrier Substances 0.000 claims description 295
- 238000003780 insertion Methods 0.000 claims description 61
- 230000000994 depressed Effects 0.000 claims description 7
- 230000001808 coupling Effects 0.000 claims description 4
- 238000010168 coupling process Methods 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 4
- 238000009877 rendering Methods 0.000 claims description 2
- 230000001419 dependent Effects 0.000 claims 1
- 230000000007 visual effect Effects 0.000 claims 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 54
- HTQBXNHDCUEHJF-XWLPCZSASA-N Exendin-4 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 HTQBXNHDCUEHJF-XWLPCZSASA-N 0.000 description 50
- 101700024131 EXE4 Proteins 0.000 description 47
- 229960001519 exenatide Drugs 0.000 description 47
- 102000004877 Insulin Human genes 0.000 description 26
- 108090001061 Insulin Proteins 0.000 description 26
- 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 21
- 230000001681 protective Effects 0.000 description 17
- 210000003491 Skin Anatomy 0.000 description 16
- 150000003839 salts Chemical class 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 7
- 229940079593 drugs Drugs 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 238000003825 pressing Methods 0.000 description 6
- 230000001960 triggered Effects 0.000 description 6
- 230000037250 Clearance Effects 0.000 description 5
- 206010012601 Diabetes mellitus Diseases 0.000 description 5
- 230000035512 clearance Effects 0.000 description 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Enoxaparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 4
- 210000003811 Fingers Anatomy 0.000 description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 230000000881 depressing Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000000979 retarding Effects 0.000 description 4
- 229940088597 Hormone Drugs 0.000 description 3
- 239000003708 ampul Substances 0.000 description 3
- 102000004965 antibodies Human genes 0.000 description 3
- 108090001123 antibodies Proteins 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 150000004676 glycans Polymers 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000000977 initiatory Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Polymers 0.000 description 3
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012689 Diabetic retinopathy Diseases 0.000 description 2
- ZFGMDIBRIDKWMY-PASTXAENSA-N Heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 2
- 229960002897 Heparin Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- 230000002429 anti-coagulation Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000000875 corresponding Effects 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 239000004026 insulin derivative Substances 0.000 description 2
- 239000003055 low molecular weight heparin Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000006011 modification reaction Methods 0.000 description 2
- 230000000069 prophylaxis Effects 0.000 description 2
- 239000012453 solvate Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229960005486 vaccines Drugs 0.000 description 2
- RWHUEXWOYVBUCI-ITQXDASVSA-N (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-3-( Chemical compound C([C@@H](C(=O)N[C@H](CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 RWHUEXWOYVBUCI-ITQXDASVSA-N 0.000 description 1
- CUWODFFVMXJOKD-UVLQAERKSA-N (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hy Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 CUWODFFVMXJOKD-UVLQAERKSA-N 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- 125000001831 (C6-C10) heteroaryl group Chemical group 0.000 description 1
- 229920000160 (ribonucleotides)n+m Polymers 0.000 description 1
- DTHNMHAUYICORS-KTKZVXAJSA-N 107444-51-9 Chemical class C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 1
- 208000004476 Acute Coronary Syndrome Diseases 0.000 description 1
- 206010002383 Angina pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108010037003 Buserelin Proteins 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- 125000000041 C6-C10 aryl group Chemical group 0.000 description 1
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 229960005153 Enoxaparin sodium Drugs 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102400000932 Gonadoliberin-1 Human genes 0.000 description 1
- 108010084340 Gonadotropin-Releasing Hormone Proteins 0.000 description 1
- 108010069236 Goserelin Proteins 0.000 description 1
- 229960002913 Goserelin Drugs 0.000 description 1
- BLCLNMBMMGCOAS-URPVMXJPSA-N Goserelin Chemical compound C([C@@H](C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 BLCLNMBMMGCOAS-URPVMXJPSA-N 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 210000003016 Hypothalamus Anatomy 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 108010000817 Leuprolide Proteins 0.000 description 1
- 229960004338 Leuprorelin Drugs 0.000 description 1
- 229940118179 Lovenox Drugs 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 208000002780 Macular Degeneration Diseases 0.000 description 1
- 206010027599 Migraine Diseases 0.000 description 1
- 208000008085 Migraine Disorders Diseases 0.000 description 1
- 208000010125 Myocardial Infarction Diseases 0.000 description 1
- 108010021717 Nafarelin Proteins 0.000 description 1
- 229960002333 Nafarelin Drugs 0.000 description 1
- 229920000272 Oligonucleotide Polymers 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 206010039073 Rheumatoid arthritis Diseases 0.000 description 1
- 208000003385 Rhinitis, Allergic, Seasonal Diseases 0.000 description 1
- BENFXAYNYRLAIU-QSVFAHTRSA-N Terlipressin Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CN)CSSC1 BENFXAYNYRLAIU-QSVFAHTRSA-N 0.000 description 1
- 108010010056 Terlipressin Proteins 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 210000003813 Thumb Anatomy 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 229960004824 Triptorelin Drugs 0.000 description 1
- 206010057362 Underdose Diseases 0.000 description 1
- 210000003462 Veins Anatomy 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 230000003042 antagnostic Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 201000001320 atherosclerosis Diseases 0.000 description 1
- 229960002719 buserelin Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000023298 conjugation with cellular fusion Effects 0.000 description 1
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 1
- NFLWUMRGJYTJIN-PNIOQBSNSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-PNIOQBSNSA-N 0.000 description 1
- 229960004281 desmopressin Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 101710038873 glc-1 Proteins 0.000 description 1
- 125000000267 glycino group Chemical group [H]N([*])C([H])([H])C(=O)O[H] 0.000 description 1
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 1
- 229960001442 gonadorelin Drugs 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 description 1
- 229910000042 hydrogen bromide Chemical class 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000000960 hypophysis hormone Substances 0.000 description 1
- 230000003116 impacting Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002452 interceptive Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000003340 mental Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 125000001116 prolino group Chemical group [H]OC(=O)C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000001105 regulatory Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 229960003813 terlipressin Drugs 0.000 description 1
- VXKHXGOKWPXYNA-PGBVPBMZSA-N triptorelin Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 VXKHXGOKWPXYNA-PGBVPBMZSA-N 0.000 description 1
- 230000021037 unidirectional conjugation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M2005/2006—Having specific accessories
- A61M2005/2013—Having specific accessories triggering of discharging means by contact of injector with patient body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M2005/206—With automatic needle insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M2005/2073—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically preventing premature release, e.g. by making use of a safety lock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M2005/2073—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically preventing premature release, e.g. by making use of a safety lock
- A61M2005/208—Release is possible only when device is pushed against the skin, e.g. using a trigger which is blocked or inactive when the device is not pushed against the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M5/321—Means for protection against accidental injuries by used needles
- A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
- A61M5/3245—Constructional features thereof, e.g. to improve manipulation or functioning
- A61M2005/3247—Means to impede repositioning of protection sleeve from needle covering to needle uncovering position
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/582—Means for facilitating use, e.g. by people with impaired vision by tactile feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/2033—Spring-loaded one-shot injectors with or without automatic needle insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
- A61M5/2422—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule
- A61M5/2429—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule by telescoping of ampoules or carpules with the syringe body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31501—Means for blocking or restricting the movement of the rod or piston
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31566—Means improving security or handling thereof
- A61M5/3157—Means providing feedback signals when administration is completed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
- A61M5/31578—Constructional features or modes of drive mechanisms for piston rods based on axial translation, i.e. components directly operatively associated and axially moved with plunger rod
- A61M5/3158—Constructional features or modes of drive mechanisms for piston rods based on axial translation, i.e. components directly operatively associated and axially moved with plunger rod performed by axially moving actuator operated by user, e.g. an injection button
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3202—Devices for protection of the needle before use, e.g. caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3202—Devices for protection of the needle before use, e.g. caps
- A61M5/3204—Needle cap remover, i.e. devices to dislodge protection cover from needle or needle hub, e.g. deshielding devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M5/321—Means for protection against accidental injuries by used needles
- A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
- A61M5/3257—Semi-automatic sleeve extension, i.e. in which triggering of the sleeve extension requires a deliberate action by the user, e.g. manual release of spring-biased extension means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M5/321—Means for protection against accidental injuries by used needles
- A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
- A61M5/326—Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/46—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for controlling depth of insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/50—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile
- A61M5/5086—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile for indicating if defective, used, tampered with or unsterile
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2270/00—Control; Monitoring or safety arrangements
- F04C2270/04—Force
- F04C2270/042—Force radial
- F04C2270/0421—Controlled or regulated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T403/00—Joints and connections
- Y10T403/32—Articulated members
- Y10T403/32254—Lockable at fixed position
- Y10T403/32467—Telescoping members
- Y10T403/32475—Telescoping members having detent
- Y10T403/32501—Cam or wedge
Abstract
auto-injector (1) for administering a dose of a liquid medicament (M) is disclosed. It is an object of the present invention to provide an improved auto-injector. One trigger button causes the injection to activate and then retract automatically after administering the medicament. The auto-injector comprising an elongate case (12) arranged to be held by a user with a tubular chassis (2) telescoped in the case (12) and biased against the case (12) so as to protrude from it. Additionally a syringe (3) with a hollow injection needle (4), a drive spring (8) and a plunger (9) for forwarding load of the drive spring (8) to a stopper (6) of the syringe (3) is contained within the case. A trigger button (13), distally arranged in or on the case (12), is initially coupled to the case (12) so as to protrude distally from the case (12) and interlocked to the chassis (2) in a manner preventing the trigger button (13) from disengaging the case (12) and thus preventing actuation of the trigger button (13) in an initial position. The case (12) is also arranged to translate in the proximal direction (P) against the bias relative to the chassis (2) when the chassis (2) is pressed against an injection site thereby also translating the trigger button (13) releasing the interlock to the chassis (2) so as to allow actuation of the trigger button (13). The trigger button (13) is arranged to lock in a more proximal position on actuation. or comprising an elongate case (12) arranged to be held by a user with a tubular chassis (2) telescoped in the case (12) and biased against the case (12) so as to protrude from it. Additionally a syringe (3) with a hollow injection needle (4), a drive spring (8) and a plunger (9) for forwarding load of the drive spring (8) to a stopper (6) of the syringe (3) is contained within the case. A trigger button (13), distally arranged in or on the case (12), is initially coupled to the case (12) so as to protrude distally from the case (12) and interlocked to the chassis (2) in a manner preventing the trigger button (13) from disengaging the case (12) and thus preventing actuation of the trigger button (13) in an initial position. The case (12) is also arranged to translate in the proximal direction (P) against the bias relative to the chassis (2) when the chassis (2) is pressed against an injection site thereby also translating the trigger button (13) releasing the interlock to the chassis (2) so as to allow actuation of the trigger button (13). The trigger button (13) is arranged to lock in a more proximal position on actuation.
Description
Auto-injector
Technical Field
The invention relates to auto-injectors for administering a dose of a liquid
medicament.
Background of the Invention
Administering an injection is a process which presents a number of risks and
challenges for users and healthcare professionals, both mental and physical.
Injection devices (i .e. devices capable of delivering medicaments from a
medication container) typically fall into two categories – manual devices and auto-
injectors.
In a manual device – the user must provide the mechanical energy to drive the
fluid through the needle. This is typically done by some form of button / plunger
that has to be continuously pressed by the user during the injection. There are
numerous disadvantages to the user from this approach. If the user stops
pressing the button / plunger then the injection will also stop. This means that the
user can deliver an underdose if the device is not used properly (i .e. the plunger
is not fully pressed to its end position). Injection forces may be too high for the
user, in particular if the patient is elderly or has dexterity problems.
The extension of the button/plunger may be too great. Thus it can be
inconvenient for the user to reach a fully extended button. The combination of
injection force and button extension can cause trembling / shaking of the hand
which in turn increases discomfort as the inserted needle moves.
Auto-injector devices aim to make self-administration of injected therapies easier
for patients. Current therapies delivered by means of self-administered injections
include drugs for diabetes (b oth insulin and newer GLP-1 class drugs), migraine,
hormone therapies, anticoagulants etc.
Auto-injectors are devices which completely or partially replace activities involved
in parenteral drug delivery from standard syringes. These activities may include
removal of a protective syringe cap, insertion of a needle into a patient’s skin,
injection of the medicament, removal of the needle, shielding of the needle and
preventing reuse of the device. This overcomes many of the disadvantages of
manual devices. Injection forces / button extension, hand-shaking and the
likelihood of delivering an incomplete dose are reduced. Triggering may be
performed by numerous means, for example a trigger button or the action of the
needle reaching its injection depth. In some devices the energy to deliver the fluid
is provided by a spring.
US 2002/0095120 A1 discloses an automatic injection device which automatically
injects a pre-measured quantity of fluid medicine when a tension spring is
released. The tension spring moves an ampoule and the injection needle from a
storage position to a deployed position when it is released. The content of the
ampoule is thereafter expelled by the tension spring forcing a piston forward
inside the ampoule. After the fluid medicine has been injected, torsion stored in
the tension spring is released and the injection needle is automatically retracted
back to its original storage position.
Summary of the Invention
It is an object of the present invention to provide an improved auto-injector.
The present invention in one aspect provides an auto-injector for administering a
dose of a liquid medicament, comprising:
- an elongate case arranged to be held by a user,
- a tubular chassis telescopable in the case and biased against the case so
as to protrude proximally from the case,
- a syringe having a hollow injection needle, a drive spring and a plunger for
forwarding load of the drive spring to a stopper of the syringe,
- a trigger button distally arranged in or on the case,
wherein the trigger button is initially coupled to the case in a manner to
protrude distally from the case and interlocked to the chassis in a manner
preventing the trigger button from disengaging the case and thus preventing
depression of the trigger button in an initial position, wherein the case is arranged
to translate in the proximal direction against the bias relative to the chassis
thereby also translating the trigger button releasing the interlock to the chassis so
as to allow depression of the trigger button, wherein a carrier subassembly is
arranged comprising a tubular carrier slidably arranged relative to the chassis
inside the case, the carrier adapted to contain the syringe with the hollow injection
needle, wherein the syringe is lockable for joint axial translation with the carrier,
characterized in that the carrier is furthermore adapted to contain the drive spring
and the plunger, wherein the trigger button exhibits at least one proximal beam
arranged to be in a ramped engagement with the case in a manner to inwardly
deflect the proximal beam and decouple it from the case when the trigger button
is forced in the proximal direction against the case, wherein in the initial position
the proximal beam inwardly abuts the carrier so as to prevent inward deflection,
wherein the carrier is initially coupled to the chassis for joint axial translation by a
detent mechanism, wherein the detent mechanism is arranged to decouple the
chassis from the carrier upon depression of the trigger button thus allowing the
carrier to move relative to the chassis, wherein a first window in the carrier is
arranged so as to allow inward deflection of the proximal beam when the case is
translated in the proximal direction from the initial position, wherein the proximal
beam is arranged to engage in the first window on depression of the trigger
button abutting the carrier so as to translate it in the proximal direction relative to
the chassis, wherein the case is arranged to outwardly abut the proximal beam
engaged in the first window preventing it from disengaging the carrier such that
the trigger button locks in a more proximal position when depressed.
In the context of this specification the term proximal refers to the direction pointing
towards the patient during an injection while the term distal refers to the opposite
direction pointing away from the patient. The term inwards refers to a radial
direction pointing towards a longitudinal axis of the auto-injector whereas the term
outwards refers to the opposite direction radially pointing away from the
longitudinal axis.
The trigger button is initially coupled to the case in a manner to protrude distally
from the case and interlocked to the chassis in a manner preventing the trigger
button from disengaging the case and thus preventing actuation of the trigger
button in an initial position, wherein the case is arranged to translate in the
proximal direction against the bias relative to the chassis, e.g. when the chassis is
pressed against an injection site, thereby also translating the trigger button
releasing the interlock to the chassis so as to allow actuation of the trigger button,
wherein the trigger button is arranged to lock in a more proximal position on
actuation.
Thus a sequence of operation is defined for the auto-injector to be actuated, first
pressing it against the injection site and then to push the trigger button. This
reduces the risk of finger stick injuries particularly if the user were to be confused
which end of the auto-injector to apply against their skin. Without a sequence the
user would risk inserting the needle into their thumb which is significantly less
probable with the forced sequence.
The trigger button locking in a more proximal than the initial position indicates that
the auto-injector has already been used so the user is kept from attempting to use
it again and reminded to purchase a new one.
In the following the chassis is generally considered as being fixed in position so motion
of other components will be described relative to the chassis unless otherwise stated.
A carrier subassembly may be arranged comprising a tubular carrier slidably arranged
relative to the chassis inside the case, the carrier adapted to contain the syringe with
the hollow injection needle, the drive spring and the plunger, wherein the syringe is
lockable for joint axial translation with the carrier, wherein the trigger button exhibits at
least one proximal beam arranged to be in a ramped engagement with the case in a
manner to inwardly deflect the proximal beam and decouple it from the case when the
trigger button is forced in the proximal direction against the case, wherein in the initial
position the proximal beam inwardly abuts the carrier so as to prevent inward deflection,
wherein the carrier is initially coupled to the chassis for joint axial translation by a detent
mechanism, wherein the detent mechanism is arranged to decouple the chassis from
the carrier upon actuation of the trigger button thus allowing the carrier to move relative
to the chassis, e.g. for needle insertion, wherein a first window in the carrier is arranged
so as to allow inward deflection of the proximal beam when the case is translated in the
proximal direction from the initial position.
The proximal beam may be arranged to engage in the first window on actuation of the
trigger button abutting the carrier so as to translate it in the proximal direction relative to
the chassis, wherein the case is arranged to outwardly abut the proximal beam engaged
in the first window preventing it from disengaging the carrier. This ensures that the
trigger button remains engaged with the carrier for joint axial translation. When the
carrier is retracted at the end of injection for needle retraction, the trigger button is still
locked to the carrier and thus in a more proximal position than initially.
A control spring may be arranged around the carrier, wherein a needle insertion control
mechanism is provided for coupling a proximal end of the control spring to either the
carrier for advancing it for needle insertion or to the chassis for needle retraction
depending on the relative axial position of the carrier and the chassis, wherein a plunger
release mechanism is arranged for releasing the plunger for injection when the carrier
has at least almost reached an injection depth during needle insertion, wherein the
detent mechanism when released is arranged to allow the carrier to move relative to the
chassis so as to cause the needle insertion control mechanism to switch the proximal
end of the control spring to the carrier for needle insertion, wherein a syringe retraction
control mechanism is arranged for coupling a distal end of the control spring to either
the carrier for needle retraction or to the case otherwise.
The carrier subassembly with the integrated drive spring allows for employing a strong
drive spring without any impact on the user when triggering the auto-injector or during
needle insertion since these actions are achieved or opposed by the control spring
which can be specified considerably weaker than the drive spring. This allows for
delivering highly viscous medicaments.
There are a number of significant benefits of separating the functions between the drive
spring and the control spring in this way. The auto-injector is always needle safe, i.e. the
needle can be retracted before the injection is complete. The reliability of the auto-
injector is improved as the components for needle advance and retraction are not
loaded by the high impact of a freely expanding high force drive spring. The auto-
injector is well suited to serve as a platform as the drive spring can be swapped to
deliver different viscosity drugs without affecting the insertion or retraction functions.
This is particularly advantageous for high viscosity fluids.
Releasing the drive spring upon the needle reaching an injection depth avoids a so
called wet injection, i.e. medicament leaking out of the needle which is a problem in
conventional art auto-injectors, where both needle insertion and injection are achieved
by pushing on the stopper. The auto-injector solves the wet injection problem by the
separate springs for translation of the carrier and for drug delivery.
The auto-injector has a particularly low part count compared to most conventional auto-
injectors thus reducing manufacturing costs. The arrangement with separate control
spring and drive spring for fluid injection allows for using one design for different
viscosity liquids by just changing the drive spring, and for different volumes just by
changing the length of the plunger. This is an advantage over conventional art designs
where the main spring also powers needle insertion and/or retraction.
In an initial as delivered state of the auto-injector the proximal end of the control spring
is coupled to the chassis by the needle insertion control mechanism while the distal end
is coupled to the case by the syringe retraction control mechanism, release of the drive
spring is prevented by the plunger release mechanism, decoupling of the chassis from
the carrier is prevented by the detent mechanism.
In order to trigger an injection the auto-injector has to be pressed against an injection
site, e.g. a patient’s skin. A user, e.g. the patient or a caregiver, grabs the case with
their whole hand and pushes the chassis protruding from the proximal end against the
injection site.
When pushed against the injection site, the case translates in the proximal direction
relative to the chassis against the force of the control spring. When the case has at least
almost reached an advanced position the detent mechanism is unlocked thereby
allowing translation of the carrier relative to the chassis.
The carrier can now be translated, preferably manually by depressing the trigger button
forcing the carrier in the proximal direction. The carrier translates in the proximal
direction relative to the case and to the chassis thereby switching the needle insertion
control mechanism depending on the relative position of the carrier in the chassis so as
to decouple the proximal end of the control spring from the chassis and couple it to the
carrier, thereby releasing the control spring for advancing the carrier for needle insertion.
Alternatively the control spring could initially be coupled to the carrier by the needle
insertion control mechanism so that the carrier would be immediately advanced when
the detent mechanism is unlocked by translation of the case into the advanced position.
As the needle translated with the carrier subassembly at least almost reaches an
injection depth the drive spring is released by the plunger release mechanism thereby
allowing the drive spring to advance the plunger and the stopper for at least partially
delivering the medicament. The release of the drive spring is preferably triggered by the
carrier reaching a predefined relative position within the case.
If the auto-injector is removed from the injection site after the stopper has bottomed out
in the syringe or mid injection, the case is translated in the distal direction under load of
the control spring relative to the carrier subassembly.
As the case reaches a defined position relative to the carrier during that motion the
proximal end of the control spring is decoupled from the carrier and coupled to the
chassis by the needle insertion control mechanism. Furthermore the distal end of the
control spring is decoupled from the trigger sleeve and coupled to the carrier by the
syringe retraction control mechanism.
As the control spring now pushes against the chassis in the proximal direction and
against the carrier in the distal direction the carrier subassembly is retracted into the
chassis into a needle safe position by the control spring.
According to one embodiment the needle insertion control mechanism may comprise a
first collar biased by the control spring in the proximal direction, wherein at least one
resilient beam is proximally arranged on the first collar, wherein respective recesses are
arranged in the carrier and case, wherein a transversal extension of a head of the
resilient beam is wider than a gap between the carrier and the chassis causing the head
of the resilient beam to abut a distal face on the recess in the chassis while being
prevented from deflecting in an inward direction by the carrier or to abut a distal face on
the recess in the carrier while being prevented from deflecting in an outward direction by
the chassis thereby forwarding load from the control spring to the carrier for needle
insertion, wherein the resilient beam is arranged to be switched between the chassis
and the carrier by ramped engagement of the head to the distal faces under load of the
control spring depending on the relative longitudinal position between the chassis and
the carrier. As the head of the resilient beam may be inwardly and outwardly ramped it
may be referred to as an arrowhead.
The plunger release mechanism may comprise at least one resilient arm on the carrier
or on the plunger arranged to be in a ramped engagement to the other one of the
plunger or the carrier so as to disengage them under load of the drive spring, wherein a
peg protrudes from a distal end face of the trigger button in the proximal direction in a
manner to support the resilient arm preventing disengagement of the carrier from the
plunger and thus release of the drive spring when the carrier is in a distal position. As
soon as the control spring takes over further advancing the carrier the trigger button
may abut the case and decouple from the carrier, staying in position as the carrier
moves on. Hence the resilient arm is pulled away from the peg thus allowing deflection
of the resilient arm due to the ramped engagement under load of the drive spring for
disengaging the plunger from the carrier and releasing the drive spring for drug delivery
when the carrier has reached a predefined position during needle advancement.
In another embodiment of the plunger release mechanism the plunger is locked to the
carrier in the initial state by a ramped engagement to the carrier and by being prevented
from rotating out of this ramped engagement depending on a relative longitudinal
position of the carrier in the case, wherein the plunger is arranged to be released for
rotating out of the ramped engagement upon the needle reaching at least nearly a
predefined injection depth on translation of the carrier in the proximal direction for
advancing the needle beyond a proximal end of the auto-injector.
This plunger release mechanism is a particularly reliable and efficient way of triggering
the injection of the medicament upon the needle reaching the injection depth.
The carrier may have a longitudinal aperture, wherein an outward protrusion is arranged
on the plunger in a manner to engage a face on the carrier in the aperture, wherein at
least one of the outward protrusion or the face on the carrier is ramped so as to force
the plunger to rotate when translated, wherein an inward longitudinal rib connected to
the case inwardly protrudes into the longitudinal aperture in a manner to prevent
disengagement of the outward protrusion from the face on the carrier prior to
translation of the carrier for advancing the needle and wherein the outward protrusion
comes clear of the inward longitudinal rib on translation of the carrier for advancing the
needle so as to rotate past a proximal end of the inward longitudinal rib due to its
ramped engagement to the carrier under load of the drive spring.
The inward longitudinal rib may be arranged on a second collar arranged in the case
and initially locked to the case for joint axial translation, the second collar being part of
the syringe retraction control mechanism, wherein the syringe retraction control
mechanism is arranged to disengage from the case and engage to the carrier when the
case is moved in the distal direction from a position with the needle in the injection
depth, wherein the control spring acts with its distal end against the second collar so as
to bias the case or the carrier in the distal direction. The proximal end of the control
spring may act against the first collar.
The detent mechanism may be arranged to provide a resistive force which has to be
overcome to advance the carrier in the proximal direction for needle insertion. Once the
user applies a force on the trigger button which exceeds a pre-determined value the
detent mechanism releases, initiating the injection cycle. If the pre-determined value is
not overcome the detent mechanism pushes the carrier and trigger button back into
their prior position. This ensures that the auto-injector is always in a defined state, either
triggered or not triggered, not half triggered by the user hesitating.
The detent mechanism may also be arranged to provide a resistive force resisting
translation of the carrier in the distal direction relative to the chassis for keeping the
carrier in a defined position in a transitional state with both ends of the control spring
decoupled from the carrier. This transitional state may be required for retracting the
needle on removal from the injection site. As the carrier is biased against the injection
site by the control spring before removal from the injection site it has to be decoupled
from the proximal end of the control spring and coupled to the distal end for retraction.
The sequencing of this switching is critical as retraction will fail if both ends of the
control spring are attached to the carrier at the same time. This is overcome by
separating the switching of the ends by a significant displacement of the case, which
moves in the distal direction relative to the chassis on removal of the injection site under
load of the control spring. As the switching of the distal end of the control spring to the
carrier depends on the relative position of the case to the carrier the carrier has to be
fixed in the transitional state which is achieved by the detent mechanism.
In one embodiment the detent mechanism comprises a resilient beam on the chassis
and a rhomboid ramp member on the carrier, the resilient beam being essentially
straight when relaxed and having a first beam head arranged to interact in a ramped
engagement with a proximal fourth ramp or a distal fifth ramp on the rhomboid ramp
member in such a manner that application of a translative force on the carrier relative to
the chassis in the proximal direction with the first beam head engaged to the fourth
ramp deflects the resilient beam in one transversal direction, e.g. outwards when a
predetermined value of the translative force, at least depending on the resilience of the
resilient beam, is overcome so as to allow the first beam head to travel along one
transversal side of the rhomboid ramp member on continued relative translation of the
components. The beam head may protrude transversally from the resilient beam in a
manner to distort the resilient beam by lever action when pushed against the rhomboid
ramp member thereby also defining the predetermined value of the translative force to
be overcome by the carrier. Furthermore, the contacting faces of the first beam head
and the rhomboid ramp member may have their friction adapted to define the required
force by appropriately choosing their shape and material properties. The resilient beam
is allowed to relax when the first beam head has reached the fifth ramp thereby
engaging it in a manner that application of a translative force on the carrier in the distal
direction deflects the resilient beam in the other transversal direction, e.g. inwards when
a predetermined value of the translative force, at least depending on the resilience of
the resilient beam, is overcome so as to allow the first beam head to travel along the
other transversal side of the rhomboid ramp member on continued translation of the
carrier. The first beam head may also be allowed to relax behind the fourth ramp at the
end of this motion for preventing the carrier from being advanced again, e.g. when the
auto-injector is being heavily shaken after use.
It goes without saying that the positions of the resilient beam on the chassis and the
rhomboid ramp member on the carrier may be switched without altering the function of
the detent mechanism.
When the auto-injector or the syringe is assembled a protective needle sheath may be
attached to the needle for keeping the needle sterile and preventing both, damage to
the needle during assembly and handling and access of a user to the needle for
avoiding finger stick injuries. Removal of the protective needle sheath prior to an
injection usually requires a relatively high force for pulling the protective needle sheath
off the needle and needle hub in the proximal direction. In order to maintain pre injection
needle safety and prevent exposure of the needle translation of the syringe in the
proximal direction due to this force has to be avoided. For this purpose the case may be
arranged to lock the detent mechanism prior to being translated in the proximal direction
relative to the chassis when the chassis is being pressed against the injection site so as
to avoid translation of the carrier. This may be achieved by a rib in the case preventing
deflection of the resilient beam of the detent mechanism by supporting it outwardly.
Translation of the case is translated into the advanced position in the proximal direction
on contact to the injection site is arranged to unlock the detent mechanism rendering it
operable. This may be achieved by the rib being moved with the case so as to no longer
outwardly supporting the resilient beam of the detent mechanism. In order to ensure
that the case is not moved in the proximal direction unlocking the detent mechanism
before the protective needle sheath is removed a cap may be attached to the proximal
end of the case so as to make the chassis inaccessible before the cap is removed. The
cap preferably engages the protective needle sheath by means of a barb in a manner to
remove the protective needle sheath when the cap is being pulled off the auto-injector.
In order to facilitate removal of the cap it may have a profiled surface mating with a
surface on the case so that the cap is pulled off when rotated. The barb may be
connected to the cap in a manner allowing them to rotate independently so as to avoid
torque on the protective needle sheath when the cap is rotated in order not to distort the
needle inside the protective needle sheath.
The syringe retraction control mechanism may comprise the second collar bearing
against the distal end of the control spring and having a resilient proximal beam with a
second beam head having an inward boss. The second beam head is arranged to be in
a ramped engagement with a second case detent in the case in a manner ramping the
second beam head in the inward direction under load of the control spring in the distal
direction. The inward boss is arranged to inwardly abut the carrier for preventing inward
deflection of the second beam head and keep the second collar locked to the case. A
third recess is arranged in the carrier for allowing the inward boss to be inwardly
deflected on translation of the case in the distal direction relative to the carrier on
removal of the auto-injector from the injection site.
In an alternative embodiment the first collar and/or the second collar may also be
threaded to one of the components which they are intended to couple to the control
spring wherein the case would be arranged to prevent the threads from decoupling in
some relative longitudinal positions while allowing the collar to rotate out of the threaded
engagement in other relative longitudinal positions so as to allow the collars to switch to
the respective other component to be coupled to the control spring.
In an alternative embodiment the trigger button may be arranged distally, wherein the
case is arranged as a wrap-over sleeve trigger having a closed distal end face covering
the trigger button. In an initial state a clearance is provided between the distal end face
of the sleeve trigger and the trigger button allowing for some travel of the sleeve trigger
against the bias of the control spring in the proximal direction in a first phase before
abutting the trigger button. As soon as the sleeve trigger has contacted the trigger
button the trigger button is pushed by the sleeve trigger on further translation in a
second phase. This embodiment allows for keeping the majority of the components of
the auto-injector while only the described features need modification allowing to
customize a platform device to particular requirements. An auto-injector with a sleeve
trigger is particularly well suited for people with dexterity problems since, as opposed to
conventional art auto-injectors, triggering does not require operation of small buttons by
single fingers. Instead, the whole hand is used.
Retraction of the needle requires the user to lift the auto-injector far enough from the
injection site to allow the case or sleeve trigger to translate back in the distal direction to
switch the control spring. As it may be difficult for the user to know if the injection is
finished or not a releasable noise component may be provided, capable of, upon
release, generating an audible and/or tactile feedback to the user, wherein the noise
component is arranged to be released when the plunger reaches a position relative to
the syringe in which the stopper is located in proximity of a proximal end of the syringe,
i.e. when the injection is at least almost finished. The released noise component then
impacts on a housing component, such as the case, sleeve trigger or trigger button
indicating the end of the injection. Impacting a directly accessible component allows for
high perceptibility of the noise and direct access to the user’s hand or finger for
generating the tactile feedback. Preferably the noise component may impact the trigger
button which may be shaped as a drum for providing a loud noise.
The needle insertion depth is preferably defined by the carrier relative to the chassis not
relative to the case, so if the user flinches or fails to hold the auto-injector hard against
the injection site, only the case will move in the distal direction while the injection depth
remains constant. As long as this case motion does not exceed a set distance the case
does not yet switch the control spring for needle retraction.
The auto-injector may be operated by a number of key mechanical operations:
- The case is advanced relative to the chassis compressing the control spring
giving the user the impression of depressing a skin interlock sleeve. All other
components remain in the same place during case advance resulting in the trigger
button appearing from the distal end of the case.
- The user pushes the trigger button which can now be operated. Button
depression directly moves the carrier and hence the drive sub-assembly in the
proximal direction a set distance until the control spring takes over via the first
collar and inserts the needle into the injection site.
- The trigger button stops on the distal end of the case as the carrier continues
translating in the proximal direction. The motion of the carrier relative to the trigger
button is used to release the drive spring just before full insertion depth is reached,
e.g. by pulling a peg on the trigger button out of the carrier thus allowing the
plunger to move. The drive spring drives the plunger down the syringe barrel
expelling the medicament.
- A noise mechanism is released when the plunger is near the end of travel shortly
before the stopper bottoms out in the syringe, indicating the end of injection to the
user.
- The needle remains fully inserted until the user moves the case back a set
distance at which point the second collar decouples from the case and couples to
the carrier while the first collar decouples from the carrier and couples to the
chassis thus allowing the control spring to retract the carrier and hence the needle.
The auto-injector may preferably be used for subcutaneous or intra-muscular injection,
particularly for delivering one of an analgetic, an anticoagulant, insulin, an insulin
derivate, heparin, Lovenox, a vaccine, a growth hormone, a peptide hormone, a
proteine, antibodies and complex carbohydrates.
The term „medicament“, as used herein, means a pharmaceutical formulation
containing at least one pharmaceutically active compound,
wherein in one embodiment the pharmaceutically active compound has a molecular
weight up to 1500 Da and/or is a peptide, a proteine, a polysaccharide, a vaccine, a
DNA, a RNA, a antibody, an enzyme, an antibody, a hormone or an oligonucleotide, or
a mixture of the above-mentioned pharmaceutically active compound,
wherein in a further embodiment the pharmaceutically active compound is useful for the
treatment and/or prophylaxis of diabetes mellitus or complications associated with
diabetes mellitus such as diabetic retinopathy, thromboembolism disorders such as
deep vein or pulmonary thromboembolism, acute coronary syndrome (A CS), angina,
myocardial infarction, cancer, macular degeneration, inflammation, hay fever,
atherosclerosis and/or rheumatoid arthritis,
wherein in a further embodiment the pharmaceutically active compound comprises at
least one peptide for the treatment and/or prophylaxis of diabetes mellitus or
complications associated with diabetes mellitus such as diabetic retinopathy,
wherein in a further embodiment the pharmaceutically active compound comprises at
least one human insulin or a human insulin analogue or derivative, glucagon-like
peptide (G LP-1) or an analogue or derivative thereof, or exedin-3 or exedin-4 or an
analogue or derivative of exedin-3 or exedin-4.
Insulin analogues are for example Gly(A 21), Arg(B 31), Arg(B 32) human insulin; Lys(B 3),
Glu(B 29) human insulin; Lys(B 28), Pro(B 29) human insulin; Asp(B 28) human insulin;
human insulin, wherein proline in position B28 is replaced by Asp, Lys, Leu, Val or Ala
and wherein in position B29 Lys may be replaced by Pro; Ala(B 26) human insulin;
Des(B 28-B30) human insulin; Des(B 27) human insulin and Des(B 30) human insulin.
Insulin derivates are for example B29-N-myristoyl-des(B 30) human insulin; B29-N-
palmitoyl-des(B 30) human insulin; B29-N-myristoyl human insulin; B29-N-palmitoyl
human insulin; B28-N-myristoyl LysB28ProB29 human insulin; B28-N-palmitoyl-
LysB28ProB29 human insulin; B30-N-myristoyl-ThrB29LysB30 human insulin; B30-N-
palmitoyl- ThrB29LysB30 human insulin; B29-N-(N -palmitoyl-Υ-glutamyl)-des(B 30)
human insulin; B29-N-(N-lithocholyl-Υ-glutamyl)-des(B 30) human insulin; B29-N-(ω -
carboxyheptadecanoyl)-des(B 30) human insulin and B29-N-(ω -carboxyheptadecanoyl)
human insulin.
Exendin-4 for example means Exendin-4(1 -39), a peptide of the sequence H-His-Gly-
Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-
Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2.
Exendin-4 derivatives are for example selected from the following list of compounds:
H-(L ys)4 -des Pro36, des Pro37 Exendin-4( 1 -39)- NH2,
H-(L ys)5 -des Pro36, des Pro37 Exendin-4(1 -39)- NH2,
des Pro36 [Asp28] Exendin-4(1 -39),
des Pro36 [IsoAsp28] Exendin-4(1 -39),
des Pro36 [Met(O )1 4, Asp28] Exendin-4(1 -39),
des Pro36 [Met(O ) 1 4, IsoAsp28] Exendin-4(1 -39),
des Pro36 [Trp(O 2)2 5, Asp28] Exendin-4(1 -39),
des Pro36 [Trp(O 2) 2 5, IsoAsp28] Exendin-4(1 -39),
des Pro36 [Met(O )1 4 Trp(O 2)2 5, Asp28] Exendin-4(1 -39) ,
des Pro36 [Met(O )1 4 Trp(O 2)2 5, IsoAsp28] Exendin-4(1 -39); or
des Pro36 [Asp28] Exendin-4(1 -39),
des Pro36 [IsoAsp28] Exendin-4(1 -39),
des Pro36 [Met(O )1 4, Asp28] Exendin-4(1 -39),
des Pro36 [Met(O )1 4, IsoAsp28] Exendin-4(1 -39),
des Pro36 [Trp( O 2)2 5, Asp28] Exendin-4(1 -39),
des Pro36 [Trp(O 2)2 5, IsoAsp28] Exendin-4(1 -39),
des Pro36 [Met( O )1 4 Trp(O 2)2 5, Asp28] Exendin-4(1 -39),
des Pro36 [Met(O ) 1 4 Trp(O 2) 2 5, IsoAsp28] Exendin-4(1 -39),
wherein the group -Lys6-NH2 may be bound to the C-terminus of the Exendin-4
derivative;
or an Exendin-4 derivative of the sequence
H-(L ys)6 -des Pro36 [Asp28] Exendin-4( 1 -39)- Lys6-NH2,
des Asp28 Pro36, Pro37, Pro38Exendin-4(1 -39)- NH2,
H-(L ys)6 -des Pro36, Pro38 [Asp28] Exendin-4(1 -39)- NH2,
H-Asn-(G lu)5 des Pro36, Pro37, Pro38 [Asp28] Exendin-4(1 -39)- NH2,
des Pro36, Pro37, Pro38 [Asp28] Exendin-4(1 -39)- ( L ys)6 -NH2,
H-(L ys)6 -des Pro36, Pro37, Pro38 [Asp28] Exendin-4( 1 -39)- (L ys)6 -NH2,
H-Asn-(G lu)5 -des Pro36, Pro37, Pro38 [Asp28] Exendin-4( 1 -39)- (L ys)6 -NH2,
H-( L ys)6 -des Pro36 [Trp(O 2)2 5, Asp28] Exendin-4(1 -39)- Lys6-NH2,
H-des Asp28 Pro36, Pro37, Pro38 [Trp(O 2)2 5] Exendin-4(1 -39)- NH2,
H-( L ys)6 -des Pro36, Pro37, Pro38 [Trp(O 2)2 5, Asp28] Exendin-4(1 -39)- NH2,
H-Asn-(G lu)5 -des Pro36, Pro37, Pro38 [Trp(O 2)2 5, Asp28] Exendin-4(1 -39)- NH2,
des Pro36, Pro37, Pro38 [Trp(O 2)2 5, Asp28] Exendin-4(1 -39)- (L ys)6 -NH2,
H-(L ys) 6 -des Pro36, Pro37, Pro38 [Trp( O 2)2 5, Asp28] Exendin-4(1 -39)- (L ys)6 -NH2,
H-Asn-(G lu)5 -des Pro36, Pro37, Pro38 [Trp(O 2)2 5, Asp28] Exendin-4(1 -39)- (L ys)6 -NH2,
H-(L ys)6 -des Pro36 [Met(O )1 4, Asp28] Exendin-4(1 -39) - Lys6-NH2,
des Met(O )1 4 Asp28 Pro36, Pro37, Pro38 Exendin-4( 1 -39)- NH2,
H-(L ys)6 -desPro36, Pro37, Pro38 [Met(O )1 4, Asp28] Exendin-4( 1 -39)- NH2,
H-Asn-(G lu)5 -des Pro36, Pro37, Pro38 [Met(O )1 4, Asp28] Exendin-4(1 -39)- NH2,
des Pro36, Pro37, Pro38 [Met(O )1 4, Asp28] Exendin-4(1 -39) - (L ys)6 -NH2,
H-(L ys)6 -des Pro36, Pro37, Pro38 [Met(O )1 4, Asp28] Exendin-4(1 -39) - (L ys)6 -NH2,
H-Asn-(G lu)5 des Pro36, Pro37, Pro38 [Met(O )1 4, Asp28] Exendin-4(1 -39)- (L ys)6 -NH2,
H-Lys6-des Pro36 [Met(O )1 4, Trp(O 2)2 5, Asp28] Exendin-4(1 -39)- Lys6-NH2,
H-des Asp28 Pro36, Pro37, Pro38 [Met(O )1 4, Trp( O 2)2 5] Exendin-4(1 -39)- NH2,
H-(L ys)6 -des Pro36, Pro37, Pro38 [Met(O ) 1 4, Asp28] Exendin-4(1 -39)- NH2,
H-Asn-(G lu)5 -des Pro36, Pro37, Pro38 [Met( O ) 1 4, Trp(O 2) 2 5, Asp28] Exendin-4(1 -39)-
NH2,
des Pro36, Pro37, Pro38 [Met(O )1 4, Trp(O 2)2 5, Asp28] Exendin-4(1 -39)- (L ys)6 -NH2,
H-(L ys) 6 -des Pro36, Pro37, Pro38 [Met( O )1 4, Trp(O 2)2 5, Asp28] Exendin-4(S 1-39) -
(L ys)6 -NH2,
H-Asn-(G lu)5 -des Pro36, Pro37, Pro38 [Met(O )1 4, Trp(O 2)2 5, Asp28] Exendin-4(1 -39)-
(L ys)6 -NH2;
or a pharmaceutically acceptable salt or solvate of any one of the afore-mentioned
Exedin-4 derivative.
Hormones are for example hypophysis hormones or hypothalamus hormones or
regulatory active peptides and their antagonists as listed in Rote Liste, ed. 2008,
Chapter 50, such as Gonadotropine (Fo llitropin, Lutropin, Choriongonadotropin,
Menotropin), Somatropine (S omatropin), Desmopressin, Terlipressin, Gonadorelin,
Triptorelin, Leuprorelin, Buserelin, Nafarelin, Goserelin.
A polysaccharide is for example a glucosaminoglycane, a hyaluronic acid, a heparin, a
low molecular weight heparin or an ultra low molecular weight heparin or a derivative
thereof, or a sulphated, e.g. a poly-sulphated form of the above-mentioned
polysaccharides, and/or a pharmaceutically acceptable salt thereof. An example of a
pharmaceutically acceptable salt of a poly-sulphated low molecular weight heparin is
enoxaparin sodium.
Pharmaceutically acceptable salts are for example acid addition salts and basic salts.
Acid addition salts are e.g. HCl or HBr salts. Basic salts are e.g. salts having a cation
selected from alkali or alkaline, e.g. Na+, or K+, or Ca2+, or an ammonium ion
N+( R 1)( R2)( R 3)( R 4), wherein R1 to R4 independently of each other mean: hydrogen,
an optionally substituted C1-C6-alkyl group, an optionally substituted C2-C6-alkenyl
group, an optionally substituted C6-C10-aryl group, or an optionally substituted C6-C10-
heteroaryl group. Further examples of pharmaceutically acceptable salts are described
in "Remington's Pharmaceutical Sciences" 17. ed. Alfonso R. Gennaro (E d.), Mark
Publishing Company, Easton, Pa., U.S.A., 1985 and in Encyclopedia of Pharmaceutical
Technology.
Pharmaceutically acceptable solvates are for example hydrates.
The drive spring and control spring may be compression springs. However, they may
likewise be any kind of stored energy means such as torsion springs, gas springs etc.
Further scope of applicability of the present invention will become apparent from the
detailed description given hereinafter. However, it should be understood that the
detailed description and specific examples, while indicating preferred embodiments of
the invention, are given by way of illustration only, since various changes and
modifications within the spirit and scope of the invention will become apparent to those
skilled in the art from this detailed description.
Brief Description of the Drawings
The present invention will become more fully understood from the detailed description
given hereinbelow and the accompanying drawings which are given by way of
illustration only, and thus, are not limitive of the present invention, and wherein:
Figure 1 shows two longitudinal sections of an auto-injector in different section
planes in a state prior to use,
Figure 2 shows two longitudinal sections of the auto-injector after removal of a
cap and a protective needle sheath,
Figure 3 shows two longitudinal sections of the auto-injector with a proximal end
pressed against an injection site,
Figure 4 shows two longitudinal sections of the auto-injector with a trigger
button depressed,
Figure 5 shows two longitudinal sections of the auto-injector during needle
insertion into the injection site,
Figure 6 shows two longitudinal sections of the auto-injector with the needle
fully inserted,
Figure 7 shows two longitudinal sections of the auto-injector during injection
near the end of dose,
Figure 8 shows two longitudinal sections of the auto-injector at the end of dose,
Figure 9 shows two longitudinal sections of the auto-injector removed from the
injection site,
Figure 10 shows two longitudinal sections of the auto-injector with the needle
retracted into a needle safe position,
Figure 11 shows schematic views of a detent mechanism for controlling
movement of a carrier relative to a chassis of the auto-injector in four different
states,
Figure 12 shows schematic views of a needle insertion control
mechanism for controlling movement of a first collar in six different states,
Figure 13 shows schematic views of a syringe retraction control
mechanism in three different states
Figure 14 shows schematic views of a noise release mechanism for
audibly indicating the end of injection in three different states,
Figure 15 shows schematic views of a plunger release mechanism in
three different states,
Figure 16 shows schematic views of a button release mechanism not
according to the present invention in three different states,
Figure 17 is an isometric view of an alternative embodiment of the
plunger release mechanism,
Figure 18 is a longitudinal section of a button release mechanism,
Figure 19 shows longitudinal sections of an alternative embodiment of
the detent mechanism,
Figure 20 is a longitudinal section of a third embodiment of the detent
mechanism,
Figure 21 is a longitudinal section of an alternative embodiment of the noise
release mechanism,
Figure 22 shows longitudinal sections of an alternative embodiment of the needle
insertion control mechanism, also arranged to perform the function of
the detent mechanism on needle retraction and needle insertion,
Figure 23 is an isometric view of the needle insertion control mechanism of figure
Figure 24 shows longitudinal sections of a third embodiment of the needle
insertion control mechanism, also arranged to perform the functions of
the detent mechanism,
Figure 25 is an isometric view of the needle insertion control mechanism of figure
Figure 26 shows longitudinal sections of a third embodiment of the noise release
mechanism, and
Figure 27 is another embodiment of the auto-injector having a wrap-over sleeve
trigger instead of a trigger button.
Corresponding parts are marked with the same reference symbols in all figures.
Detailed Description of Preferred Embodiments
A ramped engagement in the terminology of this specification is an engagement
between two components with at least one of them having a ramp for engaging the
other component in such a manner that one of the components is flexed aside when the
components are axially pushed against each other provided this component is not
prevented from flexing aside.
Figures 1a and 1b show two longitudinal sections of an auto-injector 1 in different
section planes, the different section planes approximately 90° rotated to each other,
wherein the auto-injector 1 is in an initial state prior to starting an injection. The auto-
injector 1 comprises a chassis 2. In the following the chassis 2 is generally considered
as being fixed in position so motion of other components is described relative to the
chassis 2. A syringe 3, e.g. a Hypak syringe, with a hollow injection needle 4 is
arranged in a proximal part of the auto-injector 1. When the auto-injector 1 or the
syringe 3 is assembled a protective needle sheath 5 is attached to the needle 4. A
stopper 6 is arranged for sealing the syringe 3 distally and for displacing a liquid
medicament M through the hollow needle 4. The syringe 3 is held in a tubular carrier 7
and supported at its proximal end therein. The carrier 7 is slidably arranged in the
chassis 2.
A drive spring 8 in the shape of a compression spring is arranged in a distal part of the
carrier 7. A plunger 9 serves for forwarding the force of the drive spring 8 to the
stopper 6.
The drive spring 8 is loaded between a distal carrier end face 10 of the carrier 7 and a
thrust face 11 arranged distally on the plunger 9.
The carrier 7 is a key element housing the syringe 3, the drive spring 8 and the plunger
9, which are the components required to eject the medicament M from the syringe 3.
These components can therefore be referred to as a drive sub-assembly.
The chassis 2 and the carrier 7 are arranged within a tubular case 12. A trigger button
13 is arranged at a distal end of the case 12. In a plunger release mechanism 27 a peg
14 protrudes from a distal end face of the trigger button 13 in the proximal direction P
between two resilient arms 15 originating from the distal carrier end face 10 thus
preventing them from flexing towards each other in an initial state A illustrated in figure
15A. In figure 15A only one of the resilient arms 15 is shown to illustrate the principle.
Outwardly the resilient arms 15 are caught in respective first recesses 16 in a distal
plunger sleeve 17 attached distally to the thrust face 11 and arranged inside the drive
spring 8. The engagement of the resilient arms 15 in the first recesses 16 prevents axial
translation of the plunger 9 relative to the carrier 7. The resilient arms 15 are ramped in
a manner to flex them inwards on relative motion between the plunger 9 and the carrier
7 under load of the drive spring 8, which is prevented by the peg 14 in the initial state A.
The carrier 7 is locked to the chassis 2 for preventing relative translation by a detent
mechanism 18 illustrated in more detail in figures 11A to 11D.
The trigger button 13 is initially engaged to the case 12 by a button release mechanism
26 and cannot be depressed. The button release mechanism 26 is illustrated in detail in
figures 16A to 16C. Referring now to figure 16A the button release mechanism 26
comprises a resilient proximal beam 13.1 on the trigger button 13, the proximal beam
13.1 having an outward first ramp 13.2 and an inward second ramp 13.3. In an initial
state A illustrated in figure 16A the outward first ramp 13.2 is engaged in a ramped first
case detent 12.1 preventing the trigger button 13 from moving out of the distal end D.
The trigger button 13 proximally abuts both the case 12 and the carrier 7 hence being
prevented from being depressed in the proximal direction P.
Referring again to figures 1A and 1B a control spring 19 in the shape of another
compression spring is arranged around the carrier 7 and acts between a proximal first
collar 20 and a distal second collar 21. The control spring 19 is used to move the carrier
7 and hence the drive sub-assembly in the proximal direction P for needle insertion or in
the distal direction D for needle retraction.
In the state as delivered as shown in figures 1a and 1b a cap 22 is attached to the
proximal end of the case 12 and the protective needle sheath 5 is still in place over the
needle 4 and the needle hub. An inner sleeve 22.1 of the cap 22 is arranged inside the
chassis 2 and over the protective needle sheath 5. In the inner sleeve 22.1 a barb 23 is
attached. The barb 23 is engaged to the protective needle sheath 5 for joint axial
translation.
A sequence of operation of the auto-injector 1 is as follows:
A user pulls the cap 22 from the proximal end of the case 12. The barb 23 joins the
protective needle sheath 5 to the cap 22. Hence, the protective needle sheath 5 is also
removed on removal of the cap 22. Figures 2a and 2b show the auto-injector 1 with the
cap 22 and needle sheath 5 removed. The carrier 7 and syringe 3 are prevented from
moving in the proximal direction P by the detent mechanism 18 being in a state A as in
figure 11A. Referring now to figure 11A, the detent mechanism 18 comprises a resilient
beam 2.1 on the chassis 2 with an inwardly protruding first beam head 2.2. The first
beam head 2.2 has a proximal third ramp 2.3. The detent mechanism 18 further
comprises a rhomboid ramp member 7.1 on the carrier 7 having a proximal fourth ramp
7.2 and a distal fifth ramp 7.3. In state A a rounded off distal side of the first beam head
2.2 abuts the ramp member 7.1 in the distal direction D resisting movement of the
carrier 7 in the proximal direction P relative to the chassis 2. A rib on the case 12 is
provided for preventing outward deflection of the resilient beam 2.1 thereby also
preventing motion of the carrier 7 relative to the chassis 2.
Referring again to figures 2A and 2B the user grabs the case 12 and places the chassis
2 protruding from the case 12 at the proximal end P against an injection site, e.g. a
patient’s skin. As the auto-injector 1 is pressed against the injection site the case 12
translates in the proximal direction P relative to the chassis 2 into an advanced position
as illustrated in figures 3A and 3B. The second collar 21 is locked to the case 12 and is
moved with the case 12 relative to the chassis 2 and relative to nearly all other
components of the auto-injector 1 thus slightly compressing the control spring 19
against the first collar 20 which is prevented from moving in the proximal direction P by
the chassis 2 due to a needle insertion control mechanism 24 being in a state A
illustrated in detail in figure 12A. Referring now to figure 12A, a resilient member in the
shape of an arrowhead 20.1 is proximally arranged on the first collar 20. The first collar
with the arrowhead 20.1 is being forced in the proximal direction P under load of the
compressed control spring 19. An outward sixth ramp 20.2 on the arrowhead 20.1
interacts with a second distal seventh ramp 2.4 on the chassis 2 ramping the arrowhead
.1 in an inward direction I which is prevented by the arrowhead 20.1 inwardly abutting
the carrier 7. Hence, the first collar 20 cannot translate in the proximal direction P.
Referring again to figures 3A and 3B the second collar 21 is locked to the case due to a
syringe retraction control mechanism 25 being in a state A illustrated in detail in figure
13A. Referring now to figure 13A, the syringe retraction control mechanism 25
comprises a resilient proximal beam 21.1 on the second collar 21, the proximal beam
21.1 having a second beam head 21.2 having an inward boss 21.3 and a distal outward
eighth ramp 21.4. The distal outward eighth ramp 21.4 is engaged in a ramped second
case detent 12.2 in a manner ramping the second beam head 21.1 in the inward
direction I with the second collar 21 under load of the control spring 19 in the distal
direction D which is prevented by the inward boss 21.3 inwardly abutting the carrier 7.
Referring again to figures 3A and 3B, if the user was to move the case 12 away from
the injection site, the control spring 19 expands returning the auto-injector 1 to the initial
condition after removal of the cap 22 as illustrated in figures 2A and 2B.
In the state as in figures 3A and 3B the carrier 7 continues to be prevented from moving
in the proximal direction P by the detent mechanism 18, however with the case 12 in its
advanced position the detent mechanism 18 is unlocked as the rib on the case 12 has
also moved and no longer prevents outward deflection of the resilient beam 2.1.
Movement of the case 12 relative to the carrier 7, which is locked to the chassis 2 by the
detent mechanism 18, causes the button release mechanism 26 to switch to a state B
illustrated in figure 16B. The trigger button 13 cannot translate with the case 12 in the
proximal direction P as it is abutted against the carrier 7. The ramp on the first case
detent 12.1 interacts with the outward first ramp 13.2 on the proximal beam 13.1 on the
trigger button 13 deflecting the proximal beam 13.1 in the inward direction I thus
engaging the inward second ramp 13.3 on the proximal beam 13.1 in a ramped carrier
detent 7.4 arranged in the carrier 7. As the case 12 is translated further in the proximal
direction P it supports the proximal beam 13.1 outwardly thus locking the trigger button
13 to the carrier 7. The trigger button 13 now protrudes from the distal end D of the
chassis 12 and is ready to be pressed.
In the state as in figures 3A and 3B the user depresses the trigger button 13 in the
proximal direction P. As the trigger button 13 abuts against the carrier 7 the carrier 7 is
pushing in the proximal direction P against the chassis 2, the carrier 7 and the chassis 2
interacting in the detent mechanism 18. The force exerted by the user pressing the
trigger button 13 is resolved through the chassis 2 onto the injection site, not between
the trigger button 13 and the case 12. The detent mechanism 18 provides a resistive
force when the user pushes the trigger button 13. Once the user applies a force which
exceeds a pre-determined value the detent mechanism 18 releases, initiating the
injection cycle. Referring now to figure 11B showing the detent mechanism 18 in a state
B, the resilient beam 2.1 on the chassis 2 begins to bow under load from the rhomboid
ramp member 7.1 on the carrier 7, storing elastic energy. Despite the proximal fourth
ramp 7.2 on the ramp member 7.1 friction between the contacting faces of the first
beam head 2.2 and the proximal fourth ramp 7.2 prevents movement of the first beam
head 2.2 in the outward direction O until the straightening force in the resiliently
deformed beam 2.1 is sufficiently large to overcome it. At this point the resilient beam
2.1 is deflected in the outward direction O moving out of the way of the carrier 7 thus
allowing the carrier 7 to translate in the proximal direction P. When the carrier 7 travels
sufficiently far in the proximal direction P the rhomboid ramp member 7.1 on the carrier
7 passes under the first beam head 2.2 thus allowing it to relax and move back in the
inward direction I distally behind the rhomboid ramp member 7.1 in a state C illustrated
in figure 11C at the same time constraining translation of the carrier 7 in the distal
direction D relative to the chassis 2.
Once the carrier 7 slides far enough in the proximal direction P relative to the first collar
the needle insertion control mechanism 24 is switched to a state B as illustrated in
figure 12B. In figure 12B the carrier 7 has been translated in the proximal direction P in
such a manner that the arrowhead 20.1 on the first collar 20 is no longer inwardly
supported. This may be achieved by a second recess 7.5 in the carrier 7. The
arrowhead 20.1 is now deflected in the inward direction I into the second recess 7.5
under load of the control spring 19 arriving at a state C as illustrated in figure 12C. The
first collar 20 is now decoupled from the chassis 2. Instead, the arrowhead 20.1 couples
the first collar 20 to the carrier 7 by an inward ninth ramp 20.3 engaging a distal tenth
ramp 7.6 on the carrier 7 at the proximal end of the second recess 7.5. Hence, the
control spring 19 continues moving the carrier 7 in the proximal direction P from this
point. Whilst the user advances the needle 4 by a proportion of its travel, the control
spring 19 takes over insertion before the needle 4 protrudes from the proximal end P.
Therefore the user experience is that of pressing a button, rather than manually
inserting a needle.
The detent mechanism 18 relies on the user applying a force rather than a displacement.
Once the force applied exceeds the force required to switch the detent the user will
push the trigger button 13 fully, ensuring that the first collar 20 will always switch. If the
user fails to pass the detent, the trigger button 13 returns to its unused state ready for
use as illustrated in figures 3A and 3B. This feature avoids the auto-injector 1 arriving in
an undefined state.
Figures 4A and 4B show the auto-injector 1 with the trigger button 13 depressed
sufficiently for the control spring 19 to couple on to the carrier 7 and continue moving
the carrier 7 forwards, but not yet abutting the case 12.
The carrier 7 coupled to the first collar 20 is translated in the proximal direction P driven
by the control spring 19. As the syringe 3 is arranged for joint axial translation with the
carrier 3 the syringe 3 and needle 4 are also translated resulting in the needle 4
protruding from the proximal end P and being inserted into the injection site. The trigger
button 13 returns to its initial position relative to the case 12 and latches back to the
case 12 from the carrier 7 as in state A in figure 16 A. The carrier 7 translates further in
the proximal direction P preventing inward deflection of the proximal beam 13.1 so the
outward first ramp 13.2 cannot disengage from the first case detent 12.1.
Immediately prior to the needle 4 reaching full insertion depth as illustrated in figures 5A
and 5B the peg 14 on the trigger button 13 is completely pulled out from between the
resilient arms 15 on the carrier 7. Hence, the plunger release mechanism 27 arrives in a
state B shown in figure 15B with the resilient arms 15 no longer inwardly supported by
the peg 14. Due to the ramped engagement of the resilient arms 15 in the first recess
16 they are deflected in the inward direction I under load of the drive spring 8 arriving in
a state B illustrated in figure 15C. Hence, the plunger 9 is released from the carrier 7
and driven in the proximal direction P by the drive spring 8, ready to inject the
medicament M. The force to pull the peg 14 out from between the resilient arms 15 is
provided by the control spring 19 while the force required to deflect the resilient arms 15
out of engagement to the plunger 9 is provided by the drive spring 8.
While the plunger 9 moves and closes a gap to the stopper 6 the movement of the
carrier 7 in the proximal direction P is completed by the control spring 19 pushing the
first collar 20. As the carrier 7 moves with respect to the chassis 2 during needle
insertion the needle insertion mechanism 24 arrives in a state D illustrated in figure 12D.
The arrowhead 20.1 has moved with the carrier 7 and is still kept inwardly deflected by
the chassis 2 thus preventing the first collar 20 from disengaging the carrier 7. The
arrowhead 20.1 must be able to deflect in the outward direction O to allow retraction
which will be discussed below. In order to allow outward deflection the arrowhead 20.1
travels proximally beyond the part of the chassis 2 shown in figures 12A to 12F next to
an aperture 2.5 in the chassis 2. However, as long as the case 12 is being kept pressed
against the injection site and not allowed to return in the distal direction D beyond a
predefined distance under load of the control spring 19 the arrowhead 20.1 will be kept
from deflecting in the outward direction O by a first rib 12.3 on the case 12 (n ot
illustrated in figures 12A to F, see figures 5A to 8A) during about the second half of its
motion for needle insertion.
The needle 4 is now fully inserted into the injection site as illustrated in figures 6A and
6B. The time between the trigger button 13 pressed and the needle 4 being fully
inserted is very short, however several mechanical operations take place in this time.
The needle insertion depth is defined by the carrier 7 relative to the chassis 2 not
relative to the case 12, so if the user flinches or fails to hold the auto-injector 1 hard
against the skin, only the case 12 will move in the distal direction D while the injection
depth remains constant.
As soon as the plunger 9 has closed the gap to the stopper 6 under force of the drive
spring 8 the stopper 6 is pushed in the proximal direction P within the syringe 3
displacing the medicament M through the needle 4 into the injection site.
Immediately prior to the end of injection with the stopper 6 having almost bottomed out
in the syringe 3 as illustrated in figures 7A and 7B a noise component 28 is released.
The stack up of tolerances, most notably due to the syringe 3 requires that the noise
must always be released prior to the end of injection. Otherwise, with certain
combinations of parts, the noise would not always release. The noise component 28
comprises an elongate portion 28.1 arranged within the distal plunger sleeve 17 and a
distal end plate 28.2 arranged between the carrier end face 10 and an end face of the
trigger button 13. Two second resilient arms 30 originate from the distal carrier end face
and extend in the proximal direction P. A noise spring 29 is arranged to bias the
noise component 28 in the distal direction D relative to the carrier 7 by proximally
bearing against a rib on the second resilient arms 30 and distally against the noise
component 28 (n ot illustrated).
Note: the noise component 28 is not illustrated in figures 16A, B and C for clarity since it
does not affect the function of the button release mechanism 26. A noise release
mechanism 31 for releasing the noise component 28 is schematically illustrated in
figures 14A, 14B and 14C. Referring now to figure 14A, the noise release mechanism
31 comprises the second resilient arms 30. A ramped inward boss 30.1 is arranged on
each second resilient arm 30 which is engaged to a respective outward eleventh ramp
28.3 on the elongate portion 28.1 of the noise component 28 in such a manner that the
second resilient arm 30 is deflected in the outward direction O under load of the noise
spring 29. In an initial state A of the noise release mechanism 31 the second resilient
arms 30 are prevented from being outwardly deflected by outward support of the distal
plunger sleeve 17 thus preventing translation of the noise component 28 relative to the
carrier 7. The noise release mechanism 31 remains in state A until immediately prior to
the end of injection with the stopper 6 having almost bottomed out in the syringe 3 as
illustrated in figures 7A and 7B. At this point the plunger 9 has been translated in the
proximal direction P relative to the carrier 7 to such an extent that the second resilient
arms 30 are no longer supported by the distal plunger sleeve 17. The noise release
mechanism 31 has thus arrived in a state B illustrated in figure 14B. Due to the ramped
engagement between the ramped inward boss 30.1 and the outward eleventh ramp
28.3 the second resilient arm 30 is outwardly deflected under load of the noise spring 29
thus disengaging the noise component 28 from the carrier 7 and allowing the noise
component 28 to move in the distal direction D driven by the noise spring 29 in a state C
illustrated in figure 14C. Hence, the noise component 28 is accelerated in the distal
direction D and the distal end plate 28.2 impacts on the inside of the trigger button 13
producing audible and tactile feedback to the user that the injection is about finished.
Figures 8A and 8B show the auto-injector 1 with the stopper 6 having entirely bottomed
out in the syringe 3.
As mentioned above the user is able to let the case 12 move by a few millimetres in the
distal direction D under the force of the control spring 19 without affecting the position of
the needle 4 as long as that motion is below a predefined distance. If the user wishes to
end the injection, at any time, they must allow the case 12 to move in the distal direction
D beyond that distance. Figures 9A and 9B show the auto-injector 1 lifted from the
injection site with the case 12 moved all the way in the distal direction D so that the
chassis 2 protrudes from the proximal end of the case 12. As the case 12 is moved the
first collar 20 releases the carrier 7 and then the second collar 21 releases from the
case 12 and pulls the carrier 7 in the distal direction D. The sequencing of this switching
is critical as retraction will fail if both collars 20, 21 are attached to the carrier 7 at the
same time. This is overcome by separating the switching of the collars 20, 21 by a
significant displacement of the case 12.
The switching of the first collar 20 is illustrated in figures 12E and F. In figure 12E the
case 12 has been allowed to move in the distal direction D under load of the control
spring 19 during removal of the auto-injector 1 from the injection site. The first rib 12.3
(n ot illustrated, see figure 9A) is removed from outwardly behind the arrowhead 20.1.
The first collar 20 is still being pushed in the proximal direction P by the control spring
19. Due to the engagement of the inward ninth ramp 20.3 on the arrowhead 20.1 with
the distal tenth ramp 7.6 on the carrier 7 the arrowhead 20.1 is deflected in the outward
direction O into the aperture 2.5 of the chassis 2 ( i llustrated in figures 12A to 12F), the
needle insertion control mechanism 24 arriving in a state E as illustrated in figure 12E,
decoupling the first collar 20 from the carrier 7 and latching it to the chassis 2.
As the case 12 is moving further in the distal direction D on removal from the injection
site the syringe retraction control mechanism 25 switches from its state A (c f. figure
13A) into a state B illustrated in figure 13B. The case 12 and the second collar 21
locked to the case 12 move together in the distal direction D while the carrier 7 is held in
place by the detent mechanism 18 in its state C as described above (cf . figure 11C).
Due to this motion the inward boss 21.3 on the second beam head 21.2 of the proximal
beam 21.1 on the second collar 21 no longer inwardly abuts the carrier 7. Instead the
inward boss 21.3 is deflected in the inward direction I into a third recess 7.7 in the
carrier 7 due to the ramped engagement of the second beam head 21.1 to the ramped
second case detent 12.2 under load of the control spring 19. The syringe retraction
control mechanism 25 thus arrives in a state C as illustrated in figure 13C with the
second collar 21 decoupled from the case 12 and coupled to the carrier 7. The detent
mechanism 18 applies a small retarding force to the movement of the carrier 7 before
the syringe retraction control mechanism 25 switches to state C as there is a small
sliding force, applied by the second collar 21, pulling the carrier 7 in the distal direction
D on translation of the case 12 in the distal direction D when the needle insertion control
mechanism 24 has already been switched into state E. If the carrier 7 moves too far in
the distal direction D before the second collar 21 switches, the case 12 runs out of travel
before the inward boss 21.3 can deflect into the third recess 7.7 preventing retraction.
Starting from the position C of the detent mechanism 18 (c f. fig. 11C) the carrier 7 and
hence the rhomboid ramp member 7.1 are translated in the distal direction D under load
of the control spring 19. Hence, the distal fifth ramp 7.3 of the rhomboid ramp member
7.1 engages the proximal third ramp 2.3 on the first beam head 2.2 of the resilient beam
2.1 in a manner deflecting the resilient beam 2.1 in the inward direction I. This applies
the small retarding force to the movement of the carrier 7 required for ensuring the
switching of the second collar 21 to the carrier 7. The resilient beam 2.1 and the
rhomboid ramp member 7.1 are offset sideways to allow the resilient beam 2.1 to pass
without contacting the rhomboid ramp member 7.1 as soon as the first beam head 2.2 is
entirely inwardly from the ramp member 7.1 in a state D illustrated in figure 11D.
The control spring 19 is grounded at its proximal end in the case by the first collar 20
being abutted against the chassis 2. The distal end of the control spring 19 moves the
second collar 21 in the distal direction D taking with it the carrier 7 and hence the
syringe 3 with the needle 4 overcoming the detent mechanism 18 as illustrated in
figure 11D. Note that the needle 4 is retracted out of the skin by the auto-injector 1 as
soon as the user allows the case 12 to translate sufficiently far as opposed to auto-
injectors with needle shields which require the user to remove the auto-injector from the
injection site thereby themselves pulling the needle out of the skin for allowing the
needle shield to advance.
As the movement allowed of the noise component 28 is limited relative to the carrier 7 it
is no longer in contact with the trigger button 13 which has moved in the distal direction
D with the case 12 on removal from the injection site. When the retraction begins the
noise spring 29 does not provide any retarding force. Once the noise component 28 hits
the trigger button 13 again on retraction of the carrier 7 the noise spring 29 must be
recompressed, reducing the force driving the final part of retraction. In order to ensure a
reliable retraction despite this reducing force the control spring 19 must be appropriately
dimensioned.
The retraction ends when the distal collar 21 meets a first back stop 12.4 on the case 12
as in figures 10A and 10B. The arrowhead 20.1 on the first collar 20 is inwardly
supported by the carrier 7 in a state F illustrated in figure 12F and thus prevented from
deflecting in the inward direction I. The outward sixth ramp 20.2 of the arrowhead 20.1
is engaged behind the first rib 12.3 on the case 12 preventing the case 12 from being
pushed in the proximal direction P again. A clearance may be provided between the
arrowhead 20.1 and the first rib 12.3 to allow for tolerances.
The detent mechanism 18 returns to state A as in figure 11A locking the carrier 7 in
position relative to the chassis 2 as it did initially, however it cannot be unlocked now as
the case 12 cannot move relative to the chassis 2.
A tab 20.4 on the first collar 20 is now visible through an indicator window 32 in the case
12 – indicating the auto-injector 1 has been used.
Figure 17 is an isometric view of an alternative embodiment of the plunger release
mechanism 27. The plunger release mechanism 27 prevents movement of the plunger
9 in the proximal direction P relative to the carrier 7 until the carrier 7 is moved in the
proximal direction P for needle insertion. As opposed to the plunger release
mechanism 27 of figure 15, where relative movement of the carrier 7 and trigger
button 13 are used to trigger the release of the plunger 9, the alternative embodiment of
figure 17 releases the plunger 9 by movement of the carrier 7 relative to the second
collar 21. Figure 17 illustrates the plunger release mechanism 27 prior to plunger
release. The second collar 21 is shown transparent to improve clarity. The plunger 9 is
being pushed in the proximal direction P by the drive spring 8. In order for the plunger 9
to advance, it must rotate around a twelfth ramp 7.8 on the carrier 7. A ramp member
9.1 on the plunger 9 is arranged to engage this twelfth ramp 7.8. Rotation of the ramp
member 9.1 is blocked by an inward longitudinal rib 21.5 on the second collar 21
splined in a longitudinal aperture 7.9 in the carrier 7. The case 12 and the second collar
21 remain in the same position, i.e. coupled to each other for joint axial translation. On
depression of the trigger button 13 the carrier 13 and the plunger 9 being part of the
drive sub-assembly are moved in the proximal direction P, first by the user pressing the
trigger button 13 and then by the control spring 19 taking over via the first collar 20 as
described above. Once the carrier 7 moves sufficiently far in the proximal direction P
relative to the second collar 21 the ramp member 9.1 on the collar 9 comes clear of the
longitudinal rib 21.5 on the second collar 21 and can rotate past the proximal end of the
longitudinal rib 21.5 due to its ramped engagement to the twelfth ramp 7.8 under load of
the drive spring 8. Hence, the drive spring 8 advances the plunger 9 in the proximal
direction P for injecting the medicament M.
Figure 18 is a longitudinal section of an alternative embodiment of the button release
mechanism 26. Other than the button release mechanism 26 of figure 16 which gives
the appearance of a revealing trigger button 13 on skin contact by switching the ground
of the trigger button 13 between the carrier 7 and the case 12, the button release
mechanism 26 of figure 18 starts with the trigger button 13 locked but protruding from
the distal end of the case 12. Once the carrier 7 has moved in the distal direction D on
skin contact of the chassis 2, it is possible to depress the trigger button 13 and activate
the auto-injector 1. This ensures a sequenced operation.
In the embodiment of figure 18 the trigger button 13 has two proximal beams 13.1, each
of them having a ramped outward boss 13.4. In the initial state shown in figure 18 the
ramped outward bosses 13.4 are engaged in respective fourth recesses 12.5 in the
case 12. Disengaging the ramped outward bosses 13.4 from the fourth recesses 12.5 is
prevented by the carrier 7 inwardly supporting the proximal beams 13.1 in a manner to
keep the proximal beams 13.1 from deflecting inwardly. Inward protrusions 13.5 on the
proximal beams 13.1 abut against a second rib 7.10 on the carrier 7 in a manner
preventing the carrier 7 from moving further in the proximal direction P in the initial state.
Once the carrier 7 has moved in the distal direction D on skin contact of the chassis 2 a
first window 7.11 in the carrier 7 is moved behind the inward protrusion 13.5 so as to
allow the proximal beams 13.1 to be inwardly deflected due to their ramped
engagement in the fourth recesses 12.5 on depression of the trigger button 13. The
proximal beams 13.1 are now outwardly supported by the case 12 and remain engaged
to the carrier 7 even on retraction of the needle 4. The trigger button 13 does therefore
not return to its initial position, indicating that the auto-injector 1 has been used.
The button release mechanism 26 illustrated in figure 18 may preferably be combined
with the plunger release mechanism 27 illustrated in figure 17.
Figures 19A and 19B show two longitudinal sections of an alternative embodiment of
the detent mechanism 18. The detent mechanism 18 of figures 11A to 11D, which may
be referred to as a “race track” mechanism because of the first beam head 2.2 travelling
around the rhomboid ramp member 7.1 has multiple functions which control the
movement of the carrier 7 relative to the chassis 2. The alternative detent mechanism
18 of figures 19A and 19B uses three clips 7.12, 7.13, 2.6 to produce the same effect.
The first clip 7.12 is arranged as an outwardly biased resilient beam on the carrier 7
extending from the carrier 7 in the proximal direction P. the first clip 7.12 is arranged to
prevent the carrier 7 from being moved in the proximal direction P prior to the chassis 2
being depressed or rather the case 12 being translated on skin contact. The first clip
7.12 is composed of two sections side by side. A first section 7.14 prevents movement
of the carrier 7 in the proximal direction P by abutting the chassis 2 in a recess. A
second section 7.15 is arranged as an outwardly protruding clip head arranged to be
ramped inwards by a ramp feature 12.6 on the chassis 12 for releasing the first clip 7.12
thereby unlocking the carrier 7 from the chassis 2 when the case 12 is being translated
in the proximal direction P on skin contact. A longitudinal slot 2.7 in the chassis 2 is
arranged for allowing the second section 7.15 to slide in the proximal direction P once
the lock has been released. A slight friction force between the first clip 7.12 and the
chassis 2 provides the retarding force required to ensure retraction.
The second clip 7.13 is arranged as a resilient beam on the carrier 7 extending in the
distal direction D having an outwardly protruding third beam head 7.16 with a proximal
ramp. The third beam head 7.16 serves as a back stop against a third rib 2.9 on the
chassis 2 for preventing the carrier 7 moving in the distal direction D from its initial
position. The carrier 7 and chassis 2 are assembled with the second clip 7.13 in this
position prior to inserting the syringe 3 into the carrier 7 which is facilitated by the
proximal ramp on the third beam head 7.16. The syringe 3 locks the clip in place by
preventing inward deflection thus creating a fixed stop.
The third clip 2.6 is a resilient beam on the chassis 2 extending in the distal direction D.
A ramped fourth beam head 2.8 on the third clip 2.6 is arranged to inwardly engage in a
fifth recess 7.17 in the carrier 7. Once the first clip 7.12 is unlocked, the user can load
the third clip 2.6 by pressing the carrier 7 in the proximal direction P on depression of
the trigger button 13. The third clip 2.6 is loaded in compression, i.e. it will bend
outwards and release suddenly due to its ramped engagement to the carrier 7 providing
the detent functionality similar to that illustrated in figure 11B.
Figure 20 is a longitudinal section of a third embodiment of the detent mechanism 18
which is a variation on the embodiment of figures 19A and 19B. In this embodiment the
detent function of the third clip 2.6 has been added into the first clip 7.12. The lock
between the case 12 and the carrier 7 is released in the same way, but the detent is
provided by deflecting the first clip 7.12 inwards a second level which is achieved by the
chassis 2 not having a slot 2.7 for the second section 7.15. Instead the second section
7.15, once ramped inwards by the ramp feature 12.6 on the case 12 has to be further
ramped inwards inside the chassis 2 on axial load between the chassis 2 and the carrier
7, suddenly releasing their engagement.
Figure 21 is a longitudinal section of an alternative embodiment of the noise release
mechanism 31. As opposed to the noise release mechanism 31 of figure 14 where the
noise spring 29 acts between the carrier 7 and the noise component 28, in the
embodiment illustrated in figure 21 the noise spring 29 acts between the case 12 and
the noise component 28. During needle insertion the noise spring 29 is compressed as
the noise component 28 moves with the carrier 7 relative to the case 12. When the
noise component 28 is released by the plunger 9 shortly before the end of dose, the
noise component 28 moves in the distal direction D and impacts the trigger button 13.
Other than in figure 14 the noise spring 29 is not being recompressed during needle
retraction since it is grounded in the case 12 not in the carrier 7.
Figures 22A and 22B show longitudinal sections of an alternative embodiment of the
needle insertion control mechanism 24 which is also arranged to perform the detent
function of the detent mechanism 18 on needle retraction and needle insertion. Figure
23 shows a corresponding isometric view. A fourth clip 20.5 on the first collar 20 is
arranged as a resilient beam with a beam head having an inward proximal thirteenth
ramp 20.6 for engaging a fourth rib 7.18 on the carrier 7 and outwardly supported by the
case 12 so as to keep the first collar 20 engaged to the carrier 7 prior to use, during
needle insertion and during injection. When the user lifts the case 12 away from the
injection site at the end of injection, a sixth recess 12.7 in the case 12 is moved
outwardly behind the fourth clip 20.5 allowing the fourth clip 20.5 to release when the
carrier 7 is pulled in the distal direction D by the second collar 21. Since the fourth clip
.5 has to be ramped outwards a small force is required to release the fourth clip 20.5,
providing the retraction detent.
A fifth clip 2.10 on the chassis 2 abuts a block 20.7 on the first collar 20 prior to use
preventing the first collar 20 and hence the carrier 7 engaged to the first collar 20 from
moving in the proximal direction P. In order to release, the fifth clip 2.10 must be
deflected outwards and over the block 20.7. Outward deflection of the fifth clip 2.10 is
initially prevented by the case 12. Once the case 12 has moved on skin contact a
second window 12.8 in the case 12 appears outwardly from the fifth clip 2.10 allowing
outward deflection. The fifth clip 2.10 is then deflected by a fourteenth ramp 7.19 on the
carrier 7 when the carrier 7 is pushed in the proximal direction P on button depression
as the fourth clip 20.5 does allow translation of the carrier 7 in the proximal direction P
relative to the first collar 20 but not the other way round. The detent for needle insertion
is provided by having to deflect the fifth clip 2.10 when it is loaded by the control spring
Figures 24A and 24B show longitudinal sections of a third embodiment of the needle
insertion control mechanism 24, also arranged to perform the functions of the detent
mechanism 18. Figure 25 is an isometric view of the needle insertion control
mechanism 24 of figure 24.The embodiment is similar to that illustrated in figures 22A,
22B and 23. The difference is that the fifth clip 2.10 is arranged on the first collar 20 and
the block 20.7 is arranged on the chassis 2, i.e. their position has been switched, so
there are two clips 2.10 and 20.5 on the first collar 20.
The fourth clip 20.5 is identical to that in figure 22B. It keeps the first collar 20
connected to the carrier 7 until the needle retraction is triggered, ensuring full injection
depth is reached and maintained until the retraction cycle is initiated by removing the
auto-injector 1 from the skin.
The fifth clip 2.10 provides the detent for needle insertion and releases the first collar 20
from the chassis 2, initiating needle insertion. The fifth clip 2.10 prevents the first collar
and hence the carrier 7 engaged to the first collar 20 from moving in the proximal
direction P prior to use by abutting the block 20.7 on the chassis 2. In order to release,
the fifth clip 2.10 must be deflected outwards and over the block 20.7. Outward
deflection of the fifth clip 2.10 is initially prevented by the case 12. Once the case 12
has moved on skin contact the second window 12.8 in the case 12 appears outwardly
from the fifth clip 2.10 allowing outward deflection. The fifth clip 2.10 is then deflected by
the fourteenth ramp 7.19 on the carrier 7 when the carrier 7 is pushed in the proximal
direction P on button depression as the fourth clip 20.5 does allow translation of the
carrier 7 in the proximal direction P relative to the first collar 20 but not the other way
round. The detent for needle insertion is provided by having to deflect the fifth clip 2.10
when it is loaded by the control spring 19.
Figures 26A and 26B show a longitudinal section of a third embodiment of the noise
release mechanism 31. This embodiment works without the need for a dedicated noise
spring. The plunger 9 comprises a proximally ramped rib 9.2 arranged to splay two
seventh clips 7.21 on the carrier 7 immediately prior to the end of dose. When the
proximally ramped rib 9.2 has travelled past the seventh clips 7.21 they snap back and
impact the plunger 9 generating a sound. The tubular shape of the carrier 7 helps to
transmit the sound. Figure 26A shows the noise release mechanism 31 before release.
Figure 26B shows the noise release mechanism 31 after release. Proximal faces of the
seventh clips 7.21 on the carrier 7 are axially offset to facilitate assembly by lifting the
seventh clips 7.21 over the distal side of the proximally ramped rib 9.2 one by one.
Figures 27A and 27B show longitudinal sections of another embodiment of the auto-
injector 1 in different section planes, the different section planes approximately 90°
rotated to each other, wherein the auto-injector 1 is in an initial state prior to starting an
injection. The auto-injector 1 is essentially identical to the one described in figures 1 to
16. However, other than the auto-injector of figures 1 to 16 the auto-injector 1 of this
embodiment has a wrap-over sleeve trigger instead of a trigger button.
The wrap-over sleeve trigger 12 is the same component as the case 12 which has a
closed distal end face 12.10 other than the one in figures 1 to 16. An internal trigger
button 13 is arranged at the distal end inside the sleeve trigger 12. Other than in figures
1 to 16 the trigger button 13 is not visible nor does it protrude from the case 12 in any
state. In the initial state a clearance 33 is provided between the distal end face 12.10 of
the sleeve trigger 12 and the internal trigger button 13 allowing for some travel of the
sleeve trigger 12 without interfering with the trigger button 13.
As the auto-injector 1 does not differ from the auto-injector of figures 1 to 16 in other
respects it is essentially operated in the same way with the following exceptions:
As the chassis 2 is placed against the injection site the sleeve trigger 12 translates in
the proximal direction P relative to the chassis 2 into the advanced position in a first
phase of sleeve travel removing the clearance 33 between the distal end face 12.10 of
the sleeve trigger 12 and the internal trigger button 13. As in the embodiment of figures
1 to 16 this motion unlocks the detent mechanism 18 and the trigger button 13. As the
user continues to depress the sleeve trigger 12 in a second phase of sleeve travel
thereby further advancing it in the proximal direction P the distal end face 12.10 hits the
internal trigger button 13 thereby depressing it until the first collar 20 is released from
the chassis 2 and the control spring force is coupled on to the carrier 7. The carrier 7
then advances until the internal trigger button 13 stops on another rib in the case 12 and
the plunger release mechanism 27 is released (n ote the peg 14 is shorter in this
embodiment.
From a user perspective, the detent mechanism 18 is arranged to provide a resistive
force when the user reaches the second phase of sleeve travel. Internally, there is no
difference to the embodiment of figures 1 to 16 at this point.
Needle insertion is triggered by the user fully advancing the sleeve trigger 12 in the
second phase of sleeve travel thereby fully depressing the internal trigger button 13 and
overcoming the detent mechanism as in the embodiment of figures 1 to 16.
As the control spring 19 takes over on button depression fully advancing the carrier 7 for
needle insertion the internal trigger button 13 bottoms out on an internal fifth rib 12.11 in
the sleeve trigger 12 and the internal trigger button 13 switches back to being locked to
the sleeve trigger 12 as in figure 16C.
The embodiment of figures 27A and 27B may also be combined with the alternative
features illustrated in figures 17 to 26.
It goes without saying that in all ramped engagements between two components
described in the above embodiments there may be just one ramp on one or the other
component or there may be ramps on both components without significantly influencing
the effect of the ramped engagement.
List of References
1 auto-injector
2 chassis
2.1 resilient beam
2.2 first beam head
2.3 proximal third ramp
2.4 distal seventh ramp
2.5 aperture
2.6 third clip
2.7 slot
2.8 fourth beam head
2.9 third rib
2.10 fifth clip
2.11 sixth clip
3 syringe
4 hollow injection needle
5 protective needle sheath
6 stopper
7 carrier
7.1 ramp member
7.2 proximal fourth ramp
7.3 distal fifth ramp
7.4 carrier detent
7.5 second recess
7.6 distal tenth ramp
7.7 third recess
7.8 twelfth ramp
7.9 longitudinal aperture
7.10 second rib
7.11 first window
7.12 first clip
7.13 second clip
7.14 first section
7.15 second section
7.16 third beam head
7.17 fifth recess
7.18 fourth rib
7.19 fourteenth ramp
7.20 fifteenth ramp
7.21 seventh clips
8 drive spring
9 plunger
9.1 ramp member
9.2 proximally ramped rib
carrier end face
11 thrust face
12 case
12.1 first case detent
12.2 second case detent
12.3 first rib
12.4 first back stop
12.5 fourth recess
12.6 ramp feature
12.7 sixth recess
12.8 second window
12.9 third window
12.10 distal end face
12.11 fifth rib
13 trigger button
13.1 proximal beam
13.2 outward first ramp
13.3 inward second ramp
13.4 ramped outward boss
13.5 inward protrusion
13.6 second back stop
14 peg
resilient arm
16 first recess
17 distal plunger sleeve
18 detent mechanism
19 control spring
first collar
.1 arrowhead
.2 outward sixth ramp
.3 inward ninth ramp
20.4 tab
.5 fourth clip
.6 inward proximal thirteenth ramp
.7 block
.8 fifth clip
21 second collar
21.1 proximal beam
21.2 second beam head
21.3 inward boss
21.4 distal outward eighth ramp
21.5 longitudinal rib
22 cap
22.1 inner sleeve
23 barb
24 needle insertion control mechanism
25 syringe retraction control mechanism
26 button release mechanism
27 plunger release mechanism
28 noise component
28.1 elongate portion
28.2 distal end plate
28.3 outward eleventh ramp
29 noise spring
second resilient arm
.1 ramped inward boss
31 noise release mechanism
32 indicator window
33 clearance
D distal end, distal direction
I inward direction
M medicament
O outward direction
P proximal end, proximal direction
Claims (12)
1. Auto-injector for administering a dose of a liquid medicament, comprising: - an elongate case arranged to be held by a user, - a tubular chassis telescopable in the case and biased against the case so 5 as to protrude proximally from the case, - a syringe having a hollow injection needle, a drive spring and a plunger for forwarding load of the drive spring to a stopper of the syringe, - a trigger button distally arranged in or on the case, wherein the trigger button is initially coupled to the case in a manner to 10 protrude distally from the case and interlocked to the chassis in a manner preventing the trigger button from disengaging the case and thus preventing depression of the trigger button in an initial position, wherein the case is arranged to translate in the proximal direction against the bias relative to the chassis thereby also translating the trigger button releasing the interlock to the chassis so 15 as to allow depression of the trigger button, wherein a carrier subassembly is arranged comprising a tubular carrier slidably arranged relative to the chassis inside the case, the carrier adapted to contain the syringe with the hollow injection needle, wherein the syringe is lockable for joint axial translation with the carrier, characterized in that the carrier is furthermore adapted to contain the drive spring 20 and the plunger, wherein the trigger button exhibits at least one proximal beam arranged to be in a ramped engagement with the case in a manner to inwardly deflect the proximal beam and decouple it from the case when the trigger button is forced in the proximal direction against the case, wherein in the initial position the proximal beam inwardly abuts the carrier so as to prevent inward deflection, 25 wherein the carrier is initially coupled to the chassis for joint axial translation by a detent mechanism, wherein the detent mechanism is arranged to decouple the chassis from the carrier upon depression of the trigger button thus allowing the carrier to move relative to the chassis, wherein a first window in the carrier is arranged so as to allow inward deflection of the proximal beam when the case is 30 translated in the proximal direction from the initial position, wherein the proximal beam is arranged to engage in the first window on depression of the trigger button abutting the carrier so as to translate it in the proximal direction relative to the chassis, wherein the case is arranged to outwardly abut the proximal beam engaged in the first window preventing it from disengaging the carrier such that 5 the trigger button locks in a more proximal position when depressed.
2. Auto-injector according to claim 1, wherein a control spring is arranged around the carrier, and wherein a needle insertion control mechanism is provided for coupling a proximal end of the control spring to either the carrier for advancing it for needle insertion or to the chassis for needle retraction depending on the 10 relative axial position of the carrier and the chassis, wherein a plunger release mechanism is arranged for releasing the plunger for injection when the carrier has at least almost reached an injection depth during needle insertion, wherein the detent mechanism when released is arranged to allow the carrier to move relative to the chassis so as to cause the needle insertion control mechanism to switch 15 the proximal end of the control spring to the carrier for needle insertion, wherein a syringe retraction control mechanism is arranged for coupling a distal end of the control spring to either the carrier for needle retraction or to the case otherwise.
3. Auto-injector according to claim 2, wherein the needle insertion control mechanism comprises a first collar biased by the control spring in a proximal 20 direction, wherein at least one arrowhead is proximally arranged on the first collar, wherein respective recesses are arranged in the carrier and case, wherein a transversal extension of a head of the arrowhead is wider than a gap between the carrier and the chassis causing the head of the resilient beam to abut a distal face on the recess in the chassis while being prevented from deflecting in an 25 inward direction by the carrier or to abut a distal face on the recess in the carrier while being prevented from deflecting in an outward direction by the chassis thereby forwarding load from the control spring to the carrier for needle insertion, wherein the arrowhead is arranged to be switched between the chassis and the carrier by ramped engagement of the head to the distal faces under load of the 30 control spring depending on the relative longitudinal position between the chassis and the carrier.
4. Auto-injector according to claim 3, wherein in the plunger release mechanism the plunger in an initial state is locked to the carrier by a ramped engagement to the carrier and by being prevented from rotating out of this ramped engagement depending on a relative longitudinal position of the carrier in 5 the case, wherein the plunger is arranged to be released for rotating out of the ramped engagement upon the needle reaching at least nearly a predefined injection depth on translation of the carrier in the proximal direction for advancing the needle beyond a proximal end of the auto-injector.
5. Auto-injector according to claim 4, wherein the carrier has a longitudinal 10 aperture, wherein an outward protrusion is arranged on the plunger in a manner to engage a face on the carrier in the aperture, wherein at least one of the outward protrusion or the face on the carrier is ramped so as to force the plunger to rotate when translated, wherein an inward longitudinal rib connected to the case inwardly protrudes into the longitudinal aperture in a manner to prevent 15 disengagement of the outward protrusion from the face on the carrier prior to translation of the carrier for advancing the needle and wherein the outward protrusion comes clear of the inward longitudinal rib on translation of the carrier for advancing the needle so as to rotate past a proximal end of the inward longitudinal rib due to its ramped engagement to the carrier under load of the 20 drive spring.
6. Auto-injector according to claim 5, wherein the inward longitudinal rib is arranged on a second collar arranged in the case and initially locked to the case for joint axial translation, the second collar being part of a syringe retraction control mechanism, wherein the syringe retraction control mechanism is arranged 25 to disengage from the case and engage to the carrier when the case is moved in the distal direction from a position with the needle in the injection depth, wherein a control spring is arranged in the case around the carrier, the control spring acting between the second collar and the first collar so as to bias the case or the carrier in the distal direction.
7. Auto-injector according to any one of claims 1 to 6, wherein the detent mechanism comprises a resilient beam on the chassis and a rhomboid ramp member on the carrier, the resilient beam being essentially straight when relaxed and having a first beam head arranged to interact in a ramped engagement with a 5 proximal fourth ramp or a distal fifth ramp on the rhomboid ramp member in such a manner that application of a translative force on the carrier relative to the chassis in the proximal direction with the first beam head engaged to the fourth ramp deflects the resilient beam in one transversal direction when a predetermined value of the translative force, at least depending on the resilience 10 of the resilient beam, is overcome so as to allow the first beam head to travel along one transversal side of the rhomboid ramp member on continued relative translation of the components, wherein the resilient beam is allowed to relax when the first beam head has reached the fifth ramp thereby engaging it in a manner that application of a translative force on the carrier in the distal direction 15 deflects the resilient beam in the other transversal direction when a predetermined value of the translative force, at least depending on the resilience of the resilient beam, is overcome so as to allow the first beam head to travel along the other transversal side of the rhomboid ramp member on continued translation of the carrier. 20
8. Auto-injector according to any one of claims 1 to 7, wherein the case is arranged to lock the detent mechanism prior to being translated in the proximal direction relative to the chassis when the chassis is being pressed against the injection site, wherein the case when translated into an advanced position in the proximal direction is arranged to unlock the detent mechanism rendering it 25 operable.
9. Auto-injector according to any one of claims 6 to 8 when dependent upon claim 6, wherein the syringe retraction control mechanism comprises the second collar bearing against the distal end of the control spring and having a resilient proximal beam with a second beam head having an inward boss, wherein the 30 second beam head is arranged to be in a ramped engagement with a second case detent in the case in a manner ramping the second beam head in the inward direction under load of the control spring in the distal direction, wherein the inward boss is arranged to inwardly abut the carrier for preventing inward deflection of the second beam head and keep the second collar locked to the case, wherein a third recess is arranged in the carrier for allowing the inward boss to be inwardly 5 deflected on translation of the case in the distal direction relative to the carrier on removal of the auto-injector from the injection site.
10. Auto-injector according to any one of the preceding claims, wherein a releasable noise component is provided, capable of, upon release, generating an audible and/or tactile feedback to a user, wherein the noise component is 10 arranged to be released when the plunger reaches a position relative to the syringe in which the stopper is located in proximity of a proximal end of the syringe, and wherein the released noise component impacts on a housing component indicating the end of the injection.
11. Auto-injector according to claim 10, wherein the housing component of the 15 auto-injector comprises at least part of the chassis, the case, the trigger button, the carrier and/or the plunger.
12. Auto-injector according to any one of claims 3 to 11, wherein a visual use indicator is provided, comprising at least one indicator window in the case, wherein a part of the chassis is arranged to be located behind the indicator 20 window when the case is in its distal position biased by the control spring, wherein a tab on the first collar is located outwardly from the part of the chassis after the first collar has been translated in the proximal direction during needle insertion, wherein the tab and the part of the chassis exhibit a visually distinctive feature. SANOFI-AVENTIS DEUTSCHLAND GMBH WATERMARK PATENT AND TRADE MARKS ATTORNEYS P37872NZ00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11155042.2 | 2011-02-18 | ||
EP11155042A EP2489387A1 (en) | 2011-02-18 | 2011-02-18 | Auto-injector |
PCT/EP2012/052649 WO2012110580A1 (en) | 2011-02-18 | 2012-02-16 | Auto-injector |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ614208A NZ614208A (en) | 2015-07-31 |
NZ614208B2 true NZ614208B2 (en) | 2015-11-03 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240042137A1 (en) | Auto-Injector | |
US10376642B2 (en) | Auto-injector | |
US10384015B2 (en) | Auto-injector | |
AU2012217081B2 (en) | Auto-injector | |
US9623181B2 (en) | Auto-injector | |
US9656021B2 (en) | Auto-injector | |
CA2826333A1 (en) | Auto-injector | |
AU2012217082B2 (en) | Auto-injector | |
NZ614208B2 (en) | Auto-injector |